KZIA
Kazia Therapeutics Ltd ADR
NASDAQ: KZIA · HEALTHCARE · BIOTECHNOLOGY
$13.64
+9.82% today
Updated 2026-04-30
Market cap
$135.07M
P/E ratio
—
P/S ratio
71.14x
EPS (TTM)
$-7.61
Dividend yield
—
52W range
$3 – $17
Volume
0.2M
Kazia Therapeutics Ltd ADR (KZIA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-14,641.00%
ROE
-106.90%
ROA
-25.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $13.50M | $-16.23M | 59.66% | -165.16% | -120.15% |
| 2007 | $17.31M | $-20.00M | 59.84% | -156.04% | -115.53% |
| 2008 | $13.28M | $-20.25M | 69.21% | -194.57% | -152.55% |
| 2009 | $11.15M | $-18.93M | 77.37% | -213.29% | -169.80% |
| 2010 | $9.91M | $-12.35M | 77.63% | -153.69% | -124.60% |
| 2011 | $2.02M | $-6.50M | 100.00% | -564.89% | -320.89% |
| 2012 | $1.51M | $1.31M | 100.00% | -639.72% | 86.52% |
| 2013 | $1.07M | $-1.03M | 104.19% | -191.04% | -96.58% |
| 2014 | $87000.00 | $-7.47M | 100.00% | -7,357.47% | -8,583.13% |
| 2015 | $89000.00 | $-7.14M | 100.00% | -9,147.19% | -8,020.89% |
| 2016 | $4.07M | $-12.06M | 100.00% | -313.71% | -296.29% |
| 2017 | $8.79M | $-10.67M | 100.00% | -123.49% | -121.42% |
| 2018 | $13108.00 | $-6.04M | 100.00% | -95,262.44% | -46,071.10% |
| 2019 | $1565.00 | $-10.27M | 100.00% | -535,463.26% | -656,230.03% |
| 2020 | $988110.00 | $-12.47M | 100.00% | -1,234.28% | -1,261.75% |
| 2021 | $15.18M | $-8.42M | 100.00% | -41.99% | -55.46% |
| 2022 | $10000.00 | $-25.01M | 100.00% | -253,990.00% | -250,140.00% |
| 2023 | $555.00 | $-20.47M | 100.00% | -4,346,661.08% | -3,687,419.82% |
| 2024 | $2.31M | $-26.78M | 100.00% | -1,233.19% | -1,160.23% |
| 2025 | $42000.00 | $-20.70M | 100.00% | -33,850.00% | -49,290.48% |